Fundz

Deverra Therapeutics reported raising $2.39 Million in an initial SEC Form D filing, from an offering of $2.39 Million

PRIVATESep 18, 2023

Amount Raised

$2.39 Million

$2.39 Million sold, per SEC Form D (first sale Sep 8, 2023)

Round Type

Seed

SeattleBiotechnology

Quick answer

Deverra Therapeutics raised $2.39 Million in a Seed round, dated September 8, 2023. Deverra Therapeutics is based in Seattle, Washington, United States.

How much did Deverra Therapeutics raise?
Deverra Therapeutics raised $2.39 Million in a Seed round on September 8, 2023.
What does Deverra Therapeutics do?
Deverra Therapeutics is a clinical stage biotechnology company dedicated to the development of allogeneic, off-the-shelf cellular immunotherapies for on-demand treatment of patients with cancer and infectious diseases.
Where is Deverra Therapeutics based and how big is it?
Deverra Therapeutics is based in Seattle, Washington, United States.
Who are the decision-makers at Deverra Therapeutics?
Fundz holds 1 contact at Deverra Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Deverra Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Matter Bio raised an undisclosed amount (Funding Round) on October 23, 2023.
  • Lipella Pharmaceuticals raised $3.1M (Seed) on October 23, 2023.
  • VitaTek raised an undisclosed amount (Series A) on October 22, 2023.
  • INNOCAN PHARMA Corp raised an undisclosed amount (Funding Round) on October 20, 2023.
  • Stramsen BiotechInc raised $10M (Series F) on October 20, 2023.
  • Amatera raised $1.6M (Seed) on October 20, 2023.

Who to call at Deverra Therapeutics, and when

A new round usually means Deverra Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Deverra Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Deverra Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Deverra Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Deverra Therapeutics

Location

1600 FAIRVIEW AVENUE EAST

Seattle, Washington, United States

About

Deverra Therapeutics is a clinical stage biotechnology company dedicated to the development of allogeneic, off-the-shelf cellular immunotherapies for on-demand treatment of patients with cancer and infectious diseases. The company has an exclusive license to a proprietary stem cell expansion and directed-differentiation platform from the Fred Hutchinson Cancer Research Center based on more than 20 years of federally funded research and data from 5 clinical trials. This platform can be used to generate a range of unmodified and modified immune cells to treat patients with cancer and infectious diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Deverra Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Deverra Therapeutics's next move

See what Strategic adds

Deverra Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.